Lepu Medical

What Lepu Medical does

Lepu Medical Technology (Beijing) Co., Ltd. is a Chinese medical device company founded in 1999 and publicly listed on the Shenzhen Stock Exchange (300003.SZ) with a secondary listing on the SIX Swiss Exchange completed in 2024. Its subsidiary Lepu ScienTech Medical Technology Co., Ltd. is separately listed on the Hong Kong Stock Exchange (2291.HK). The company designs, manufactures, and distributes cardiovascular interventional devices, structural heart products, in vitro diagnostics, hemodialysis equipment, critical care consumables, surgical endoscopes, orthopedic implants, cardiac rhythm management devices, and active pharmaceutical ingredients, serving tertiary and secondary hospitals, cardiac catheterization laboratories, dialysis centers, and surgical facilities in 160+ countries through a hybrid model of direct subsidiaries (Germany, Netherlands, Brazil, India, Indonesia, Malaysia) plus 100+ OEM and distributor partners.

The core technology platform spans drug-eluting coronary stents (NeoVas bioresorbable, Nano+ polymer-free, GuReater CoCr), the Vesscrack intravascular lithotripsy balloon for severely calcified lesions, the ScienCrown transcatheter aortic valve system combining balloon-expandable stability with self-expanding retrievability, and the world's first biodegradable PFO/ASD/VSD occluder (MemoSorb) that gradually absorbs after promoting tissue regeneration. Adjacent technology assets include the AI-ECG arrhythmia detection platform (NMPA Class III cleared), RattleSight 60MHz IVUS imaging catheters, and the Shenda endoscopy line (laparoscopes, arthroscopes, cystoscopes) now EU MDR-certified. The portfolio is supported by 2,400+ medical patents, 210+ CE certificates, and 30+ FDA approvals.

The company monetizes primarily through B2B hardware sales of devices and consumables to hospitals and healthcare providers at quote-based institutional pricing, with revenue recognition on shipment and replenishment cycles driven by procedural volumes. Marketing relies on international cardiology conferences (CSI Frankfurt, Hospitalar, FIME), live-case training programs, clinical case studies, and Belt-and-Road-aligned academic exchanges. Reported financial data shows revenue declining from $1,677M in 2021 to $927M in 2025, with EBITDA compressed from $473M to $263M and operating income falling from $411M to $180M, indicating sustained top-line and margin contraction over the four-year window.

Name

Lepu Medical

Legal name

Lepu Medical Technology (Beijing) Co., Ltd.

Website

http://en.lepumedical.com/

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Lepu Medical is a Beijing-headquartered Chinese medical device manufacturer founded in 1999, selling cardiovascular interventional devices, structural heart products, IVD, hemodialysis, critical care, and surgical equipment to hospitals and cardiac centers in 160+ countries through direct subsidiaries and OEM/distributor channels.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)

akta.pro secondary industries

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

• Interventional cardiology devices
• Cardiovascular medical devices
• Structural heart products
• Hemodialysis equipment
• In vitro diagnostics

Headquarters

HQ city

Changping

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of cardiovascular intervention devices, structural heart products, critical care equipment, in vitro diagnostics, hemodialysis products, and surgical devices to hospitals and healthcare providers worldwide

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Lepu Medical develops, manufactures, and markets high-tech medical devices and equipment, with a core focus on cardiovascular interventional products including coronary stents, coronary balloons (PTCA, NC, and drug-coated), intravascular lithotripsy catheters, structural heart occluders, transcatheter aortic valve replacement systems, and cardiac rhythm management devices. The company also manufactures in vitro diagnostics, hemodialysis equipment, critical care catheters, surgical endoscopes, orthopedic implants, ECG and patient monitoring systems (including AI-powered ECG analysis), and active pharmaceutical ingredients.

Product overview

Lepu Medical is a comprehensive medical device company founded in 1999, offering a diversified portfolio of interventional cardiology devices, in vitro diagnostics, structural heart products, and medical consumables. The product portfolio includes coronary stents and balloons (Vesscrack IVL balloon, drug-coated balloons), structural heart occluders (MemoSorb biodegradable ASD/VSD/PFO occluders, ScienCrown TAVR system), cardiac rhythm management devices, AI-enabled ECG monitoring solutions (AI-ECG platform, NeoECG), patient monitoring systems (AIView tablet monitors), hemodialysis equipment, critical care products, surgical endoscopes, orthopedic implants, and in vitro diagnostics. The company operates across 160+ countries with 210+ CE certificates and 30+ FDA approvals, positioning itself as a leader in cardiovascular interventional medical devices with a focus on PCI solutions, structural heart interventions, and digital health monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• Vesselin: Drug Coated Coronary Balloon Catheter product line
• Vesscrack
• ScienCrown
• MemoSorb
• NeoECG
• AIView
• Shoocin
• Sailor X
• RattleSight
• RattleView
• Vasspagru
• Perdenser
• Nuva
• Frepass
• Safecath
• FireyZip
• Shenda

Products and services

• Coronary Stents Drug-eluting coronary stent systems including NeoVas bioresorbable stent, Nano+ polymer-free stent, and GuReater CoCr stent for the treatment of coronary artery disease, used by interventional cardiologists in catheterization labs.
• Coronary Balloons (PTCA, NC, and Drug-Coated) PTCA balloons, NC balloons, and drug-coated balloons (Vesselin DCB) used for lesion preparation and drug delivery during percutaneous coronary intervention procedures by interventional cardiologists.
• Vesscrack Coronary IVL Balloon Dilatation Catheter Intravascular lithotripsy balloon catheter that uses acoustic waves to modify calcium in severely calcified coronary lesions prior to stenting, used by interventional cardiologists for calcified lesion preparation.
• ScienCrown Transcatheter Aortic Valve Replacement (TAVR) System Transcatheter aortic valve replacement system that combines balloon-expandable stability with self-expanding retrievability, designed for complex aortic valve cases including horizontal hearts and severe calcifications.
• MemoSorb Biodegradable Occluders Biodegradable ASD, VSD, and PFO occluders that gradually absorb after promoting tissue regeneration, minimizing the need for permanent metal implants in the heart; used by interventional cardiologists for structural heart defect closure.
• Cardiac Rhythm Management Products Pacemakers, leads, and related equipment for cardiac rhythm management including implantable dual chamber pacemakers and electrophysiology catheters, used by electrophysiologists and cardiology departments.
• AI-ECG Platform Artificial intelligence-powered platform that processes ECG waveform data for arrhythmia detection and cardiac diagnostics, used by cardiologists and clinical staff for improved cardiac monitoring accuracy and efficiency.
• NeoECG and ECG Products Resting electrocardiographs, Holter monitors, portable ECG monitors, and pocket ECG devices, including AI-integrated tablet-based models, used for cardiac monitoring in hospitals, clinics, and ambulatory settings.
• Patient Monitors (AIView Series) Tablet patient monitors (AIView VX, V10, V12 series) with advanced multi-parameter monitoring and wireless transmission, used in hospitals, ICUs, and ambulatory care environments for continuous patient monitoring.
• Oximeters Fingertip, handheld, wrist, and wearable pulse oximeters (PC-60 series and O2 RING) for oxygen saturation monitoring in clinical and home settings.
• In Vitro Diagnostics Immunoassay (ELISA, CLIA, FIA), molecular diagnostics (PCR kits, nucleic acid extraction), hematology diagnostics, and POCT (point-of-care testing) products for clinical laboratories and hospitals.
• Hemodialysis Products Dialyzers, hemodialysis blood tubing sets, fistula needles, hemoperfusion cartridges, and Aide Series dialysis machines for renal replacement therapy, used by dialysis centers and hospitals treating end-stage renal disease.
• Critical Care Products Central venous catheters, peripherally inserted midline catheters, blood pressure transducers, arterial blood samplers, CVC accessories, and IV catheters for critical care and ICU hospital settings.
• Shenda Surgical Endoscopy Products Endoscopes, resectoscopes, cystoscopes, arthroscopes, laparoscopic instruments, and 4K fluorescence endoscope camera systems under the Shenda brand for minimally invasive surgery.
• Orthopedic Products Trauma implants (Ortho-Bridge System/OBS, locking plates, screws, Patella Ring), spinal implants, artificial joints (hip and knee systems), and sports medicine products for orthopedic surgery.
• Peripheral Intervention Products Peripheral balloons, cutting balloons, drug-coated peripheral PTA balloons, and endovenous radiofrequency ablation catheters for peripheral vascular disease intervention.
• Digital Subtraction Angiography (DSA) Systems Vicor-CV Robin C/F and Swift medical angiography X-ray systems for digital subtraction angiography imaging in cardiac catheterization labs and interventional radiology suites.
• Pharmaceutical (API) Products Active pharmaceutical ingredients including cardiovascular drugs, oncology medications, anti-infectives, and CNS drugs, sold to pharmaceutical manufacturers and formulators.
• RattleView and RattleSight IVUS Products Intravascular ultrasound (IVUS) diagnostic imaging catheter (RattleSight) and IVUS diagnostic equipment (RattleView) with 20μm resolution and 60MHz frequency for precise coronary intervention guidance.

Quantifiable outcome

• First-in-world biodegradable PFO occluder successfully used in clinical settings
• +2 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

• Thai Son Medical TechnologycoreChannel Partner/ Reseller/ DistributorStrategic partnership for distribution and co-hosting of scientific workshops on IVL technology in Vietnam with Hue Central Hospital, focusing on promoting intravascular lithotripsy for severe coronary calcified lesions
• Academy for International Business Officials (AIBO), Ministry of Commerce, P.R. ChinaflagshipStrategic or Co-development PartnerCollaboration for Seminar on Medical Consumables R&D and Application for BRI Partner Countries, hosting delegates from multiple Belt and Road Initiative partner countries to showcase Lepu medical technologies
• China Sinopharm International CorporationcoreStrategic or Co-development PartnerJoint organization of BRI partner country seminar for medical consumables R&D and application, facilitating international collaboration and market access
• Nanjing First HospitalcoreStrategic or Co-development PartnerCollaboration for training and live demonstration of IVL technology at Republican Scientific and Practical Centre of Cardiology in Belarus, with Dr. Xiaofei Gao conducting clinical education
• LEPUCARE (INDIA) VASCULAR SOLUTIONS PVT LTDcoreChannel Partner/ Reseller/ DistributorIndia subsidiary specializing in Hemodialysis, Critical Care, PCI, Coronary Heart Disease treatments, Neuro Interventions, and General Surgery product distribution
• PT LEPU COMMERCE INDONESIAminorChannel Partner/ Reseller/ DistributorIndonesia subsidiary with plans to establish presence on local e-commerce platforms including Tokopedia, Shopee, and Lazada
• LEPU TECHNOLOGY (MALAYSIA) SND. BHD.coreChannel Partner/ Reseller/ DistributorMalaysia subsidiary operating independent manufacturing facility with plans to produce Hemodialysis Products, Surgical Products, and In Vitro Diagnostic Products

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Penumbra: Neurovascular intervention company with flow diverters and embolization coils overlapping with Lepu's Nuva Flow Diverter and Perdenser embolic coil product lines in peripheral/neurovascular interventions.

Broad incumbents

• Boston Scientific: Cardiovascular heavyweight in coronary intervention (Synergy stents, IVL via Shockwave acquisition), structural heart, peripheral vascular, and endoscopy — overlapping substantially with Lepu's portfolio strategy.
• B. Braun: Global medical device and pharmaceutical company with broad hospital products portfolio including interventional cardiology, surgical instruments, IVD, and orthopedic implants — comparable to Lepu's broad hospital channel strategy.
• Medtronic: Global leader in cardiovascular medical devices including coronary stents, TAVR (CoreValve/Evolut), structural heart, cardiac rhythm management, and IVL. Direct overlap with Lepu across nearly every major cardiovascular category; benchmark competitor in both China and Western markets.
• Abbott: Major cardiovascular incumbent with leading structural heart (Amplatzer PFO/ASD occluders, MitraClip), coronary stents (Xience), and cardiac rhythm management portfolio. Closely comparable to Lepu across structural heart and coronary intervention segments.
• Teleflex: Specialty medical device company with structural heart (occluders via acquired portfolio), interventional cardiology, and surgical solutions — comparable in selected product categories to Lepu's structural heart and surgical portfolios.

Direct peers

• Edwards Lifesciences: Global TAVR market leader (Sapien platform) and structural heart specialist. Direct competitor to Lepu's ScienCrown TAVR system; benchmark for clinical evidence and premium pricing in transcatheter valve replacement.
• Shockwave Medical (J&J): Pioneer of intravascular lithotripsy (IVL) for coronary and peripheral calcified lesions — direct competitor to Lepu's Vesscrack IVL platform. Acquired by Johnson & Johnson in 2024, raising the competitive bar in IVL.
• MicroPort Scientific Corporation: China-headquartered cardiovascular and orthopedic medical device company with coronary stents, TAVR (VitaFlow), and structural heart products. Closest direct Chinese peer to Lepu in interventional cardiology and structural heart.

Regional players

• JW Medical Systems: China-focused cardiovascular intervention company specializing in drug-eluting stents and balloon products. Direct China-domestic peer to Lepu's coronary stent and balloon business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance17 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lepu Medical